Reducing the risk of stroke through appropriate targets and treatments.
On June 29, 2007, Michael H. Davidson, MD, of the University of Chicago, Chicago, IL, moderated a panel of participants, including Jan Basile, MD, Primary Care Service Line, Ralph H. Johnson VA Medical Center, and the Division of General Internal Medicine/Geriatrics, Medical University of South Carolina, Charleston, SC; Alan J. Garber, MD, PhD, Baylor College of Medicine, Houston, TX; and Robert A. Phillips, MD, PhD, University of Massachusetts Memorial Medical Center, Worcester, MA. With the publication of this first Expert Panel Discussion in Preventive Cardiology, we inaugurate a new educational feature. Periodically, we will gather a group of experts to exchange viewpoints on current issues relevant to the prevention of cardiovascular disease. It is our hope that the resulting discussion will provide the practicing clinician with data from recent trials, expert opinions on symptoms and diagnoses, and a variety of potential therapeutic approaches for the management of risk factors.
Davidson
Michael H
MH
Basile
Jan
J
Garber
Alan J
AJ
Phillips
Robert A
RA
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy; D005951:Glucose Tolerance Test; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D011379:Prognosis; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
D000959:Antihypertensive Agents; D001786:Blood Glucose; D000960:Hypolipidemic Agents